PhD Scientific Days 2026

Poster Session 3.J - Theoretical and Translational Medicine

Exploring Anti-tumor Effect of GSK3β Inhibitor Elraglusib (9-ING-41) on Cancer: Systematic Review of In vivo Studies

Name of the presenter

Ahmed, Ebsa Tofik

Institute/workplace of the presenter

Clinical Pathophysiology

Authors

Ebsa Tofik Ahmed¹, Csaba Andras Schvarcz, Qusay O. Abdalla, Evan Santo, Daniel Bosci, Zoltan Koos, Hakim Bahlok Jebur, Mohamed I . Elsalahaty, Mingming He, Yibo Gu, Cedrik Kintscher, Peter Hamar¹

1: Semmelweis University